Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

Clinical trial NCT07236099 · RECRUITING

Trial details

NCT number: NCT07236099
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prurigo Nodularis (PN)

Start date: 2025-11-27
Primary completion: 2027-03-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.